| cellular amino acid metabolic process | GO:0006520 | 103 | 0.085 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.061 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.060 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.057 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.055 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.054 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.053 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.053 | |
| oxidation reduction process | GO:0055114 | 342 | 0.051 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.051 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.051 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.051 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.049 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.048 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.048 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.048 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.046 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.046 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.043 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.043 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.043 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.041 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.041 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.040 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.040 | |
| histone lysine methylation | GO:0034968 | 50 | 0.039 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.038 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.038 | |
| chromatin organization | GO:0006325 | 206 | 0.038 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.038 | |
| organelle fission | GO:0048285 | 170 | 0.037 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.037 | |
| mrna processing | GO:0006397 | 63 | 0.037 | |
| chromatin modification | GO:0016568 | 187 | 0.036 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.036 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.036 | |
| amine metabolic process | GO:0009308 | 45 | 0.034 | |
| dna metabolic process | GO:0006259 | 303 | 0.034 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.032 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.032 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.031 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.031 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.030 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.030 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.030 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.029 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.029 | |
| synaptic transmission | GO:0007268 | 329 | 0.028 | |
| dna repair | GO:0006281 | 107 | 0.028 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.028 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.028 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.028 | |
| histone modification | GO:0016570 | 159 | 0.028 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.027 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.027 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.027 | |
| translation | GO:0006412 | 93 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| protein catabolic process | GO:0030163 | 221 | 0.026 | |
| mrna metabolic process | GO:0016071 | 84 | 0.026 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.026 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.026 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.026 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.026 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.025 | |
| atp catabolic process | GO:0006200 | 55 | 0.025 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.025 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.025 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.025 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.025 | |
| methylation | GO:0032259 | 134 | 0.025 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.025 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.025 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.025 | |
| membrane organization | GO:0061024 | 245 | 0.025 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.024 | |
| regionalization | GO:0003002 | 337 | 0.024 | |
| histone methylation | GO:0016571 | 71 | 0.023 | |
| trna metabolic process | GO:0006399 | 11 | 0.023 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.023 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.023 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.023 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.023 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.023 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.022 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.022 | |
| gonad development | GO:0008406 | 141 | 0.022 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.022 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.022 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.022 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.021 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.021 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.021 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.021 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.021 | |
| cation transport | GO:0006812 | 399 | 0.021 | |
| double strand break repair | GO:0006302 | 48 | 0.020 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.020 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.020 | |
| b cell activation | GO:0042113 | 161 | 0.020 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.020 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.020 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.020 | |
| cellular response to lipid | GO:0071396 | 145 | 0.019 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.019 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.019 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.019 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.019 | |
| nuclear division | GO:0000280 | 158 | 0.019 | |
| neuron death | GO:0070997 | 154 | 0.019 | |
| action potential | GO:0001508 | 78 | 0.019 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.019 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.019 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.019 | |
| response to light stimulus | GO:0009416 | 135 | 0.018 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.018 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.018 | |
| immune effector process | GO:0002252 | 321 | 0.018 | |
| rna processing | GO:0006396 | 105 | 0.018 | |
| gland development | GO:0048732 | 330 | 0.018 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.018 | |
| germ cell development | GO:0007281 | 185 | 0.017 | |
| cellular homeostasis | GO:0019725 | 240 | 0.017 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.017 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.017 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.017 | |
| mapk cascade | GO:0000165 | 281 | 0.017 | |
| organelle assembly | GO:0070925 | 177 | 0.017 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.017 | |
| transmembrane transport | GO:0055085 | 412 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.017 | |
| regulation of neuron death | GO:1901214 | 134 | 0.017 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.017 | |
| locomotory behavior | GO:0007626 | 195 | 0.017 | |
| rna 3 end processing | GO:0031123 | 20 | 0.016 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.016 | |
| regulation of cell motility | GO:2000145 | 236 | 0.016 | |
| stem cell differentiation | GO:0048863 | 268 | 0.016 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.016 | |
| protein secretion | GO:0009306 | 111 | 0.016 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.016 | |
| regulation of secretion | GO:0051046 | 274 | 0.016 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.016 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.016 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.016 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.015 | |
| protein ubiquitination | GO:0016567 | 171 | 0.015 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.015 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.015 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.015 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.015 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.015 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.015 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.015 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.015 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.015 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.015 | |
| cell adhesion | GO:0007155 | 329 | 0.015 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.015 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.015 | |
| regulation of protein localization | GO:0032880 | 231 | 0.015 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.015 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.014 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.014 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.014 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.014 | |
| synapse organization | GO:0050808 | 125 | 0.014 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.014 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.014 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.014 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.014 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.014 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.014 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.014 | |
| adult behavior | GO:0030534 | 135 | 0.014 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.014 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.014 | |
| cytokine production | GO:0001816 | 319 | 0.014 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.014 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.014 | |
| response to radiation | GO:0009314 | 165 | 0.014 | |
| neuronal action potential | GO:0019228 | 54 | 0.014 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.014 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.014 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.014 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.014 | |
| placenta development | GO:0001890 | 140 | 0.014 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.013 | |
| response to acid chemical | GO:0001101 | 111 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.013 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.013 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.013 | |
| protein acylation | GO:0043543 | 64 | 0.013 | |
| protein localization to membrane | GO:0072657 | 108 | 0.013 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.013 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.013 | |
| meiosis i | GO:0007127 | 60 | 0.013 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.013 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.013 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.012 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.012 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.012 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.012 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.012 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.012 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.012 | |
| maintenance of location | GO:0051235 | 89 | 0.012 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.012 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.012 | |
| mitochondrion organization | GO:0007005 | 134 | 0.012 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.012 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.012 | |
| adaptive immune response | GO:0002250 | 155 | 0.012 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.012 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.012 | |
| regulation of binding | GO:0051098 | 111 | 0.012 | |
| muscle tissue development | GO:0060537 | 308 | 0.012 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.012 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.012 | |
| regulation of cell activation | GO:0050865 | 289 | 0.012 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.012 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.012 | |
| intracellular protein transport | GO:0006886 | 204 | 0.012 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.011 | |
| spermatogenesis | GO:0007283 | 284 | 0.011 | |
| ncrna 3 end processing | GO:0043628 | 2 | 0.011 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.011 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.011 | |
| t cell activation | GO:0042110 | 289 | 0.011 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.011 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.011 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.011 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.011 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.011 | |
| response to inorganic substance | GO:0010035 | 96 | 0.011 | |
| endomembrane system organization | GO:0010256 | 147 | 0.011 | |
| cofactor biosynthetic process | GO:0051188 | 41 | 0.011 | |
| protein processing | GO:0016485 | 163 | 0.011 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.011 | |
| rna interference | GO:0016246 | 2 | 0.011 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.011 | |
| macromolecule methylation | GO:0043414 | 120 | 0.011 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.011 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.011 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.011 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.011 | |
| trna wobble uridine modification | GO:0002098 | 2 | 0.011 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.011 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.011 | |
| lateral inhibition | GO:0046331 | 1 | 0.011 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.011 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.011 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.011 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.011 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.010 | |
| endocytosis | GO:0006897 | 168 | 0.010 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.010 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.010 | |
| blastocyst development | GO:0001824 | 80 | 0.010 | |
| anion transport | GO:0006820 | 177 | 0.010 | |
| regulation of ion transport | GO:0043269 | 215 | 0.010 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.010 | |
| rna catabolic process | GO:0006401 | 29 | 0.010 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.010 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.010 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.010 | |
| response to nutrient levels | GO:0031667 | 109 | 0.010 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.010 | |
| blood circulation | GO:0008015 | 195 | 0.010 | |
| axonogenesis | GO:0007409 | 274 | 0.010 | |
| ear development | GO:0043583 | 200 | 0.010 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.010 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.010 | |
| protein alkylation | GO:0008213 | 81 | 0.010 | |
| muscle cell development | GO:0055001 | 133 | 0.010 | |
| stem cell proliferation | GO:0072089 | 117 | 0.010 | |
| oogenesis | GO:0048477 | 56 | 0.010 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.010 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 10 | 0.010 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.010 | |
